Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.18036 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.20335 | 50 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.17619 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.15451 | 50 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.15289 | 50 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.64092 | 25 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.17351 | 47 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.16167 | 49 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.14557 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.29964 | 54 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.16045 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.38795 | 56 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.14081 | 48 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.16719 | 49 |